期刊文献+

水痘-带状疱疹病毒相关性噬血细胞综合征一例并文献复习

Varicella-zoster virus-related hemophagocytic syndrome:a case report and literature review
下载PDF
导出
摘要 目的:总结水痘-带状疱疹病毒相关性噬血细胞综合征(varicella zoster virus associated hemophagocytic syndrome,VZV-HPS)的临床特点。方法:收集本院1例VZV-HPS患者的病历资料,通过检索相关的国内外文献数据库,筛选并提取17个病例进行分析。结果:18例VZV-HPS患者中男女比例3.5∶1,12例(66.7%)≤17岁。18例患者均出现皮疹和血细胞减少,17例(94.4%)发热,15例(83.3%)查见噬血细胞,13例(72.2%)ALT或Fer升高,11例(61.1%)LDH升高。治疗上主要是应用抗病毒药物、糖皮质激素、人免疫球蛋白。治疗中位周期28(5~56)天。15例患者噬血症状完全缓解,2例死亡,1例放弃治疗。结论:VZV-HPS好发于17岁以下男性,以皮疹、发热、血细胞减少、肝损害为主要表现,病情复杂凶险但治愈率高。 Objective:To summarize the clinical characteristics of varicella zoster virus-associated hemophagocytic syndrome(VZV-HPS).Methods:One VZV-HPS patient in our hospital and 17 cases reported in domestic and foreign database were analyzed.Results:Eighteen patients were enrolled.The male to female ratio was 3.5∶1 and 12 cases(66.7%)were under 17 years old.18 patients had rash and cytopenia,17(94.4%)had fever,15(83.3%)had hemophagocytes,13(72.2%)had high level of ALT or Fer,and 11(61.1%)had high level of LDH.The main treatment included antiviral drugs,glucocorticoid,human immunoglobulin.The median treatment period was 28(5-56)days.15 patients had complete remission of hemophagy,2 died and one gave up treatment.Conclusions:VZV-HPS most occurs in men under 17 years of age,and the main clinical manifestations are rash,fever,cytopenia and liver damage.The disease is complex and dangerous but the cure rate is high.
作者 李楠 焦健 尹延旭 蔡大幸 LI Nan;JIAO Jian;YIN Yanxu;CAI Daxing(Department of Dermatology,Qilu Hospital of Shandong University,Jinan 250012,China;Medical Department,Nanshan Hospital of Shandong Province,Jinan 250002,China)
出处 《中国麻风皮肤病杂志》 2022年第10期705-708,共4页 China Journal of Leprosy and Skin Diseases
关键词 水痘-带状疱疹病毒 噬血细胞综合征 临床特点 varicella-zoster virus hemophagocytic hyndrome clinical features
  • 相关文献

参考文献4

二级参考文献39

  • 1Henter JI, Home A, Arico M, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagoeytic lymphohistiocytosis. Pediatr Blood Cancer, 2007 ;48:124-131.
  • 2Janka GE. Hemophagocytic syndromes. Blood Reviews, 2007 ;21 (5) :245-253.
  • 3RouphaelNG, TaiatiNJ,Vaughan C, et al. Infections associated with hemophagocytic syndrome [ J ]. Lancet Infect D is, 2007 ; 7 ( 12 ) : 814-822.
  • 4Imashuku S. Advances in the management of hemophagocytic lymphohistiocytosis. Int J Hematol, 2000 ;72 ( 1 ) : 1-11.
  • 5Janka G, Imashuku S, Elinder G, et al. Infection and malignancy- associated hemophagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis. Hematol Oncol Clin North Am, 1998 ; 12 (2) : 435-444.
  • 6Janka G, Zur Stadt U. Familial and acquired hemophagocyticlymphohistiocytosis[ J ]. Hematology Am Soc Hematol Educ Program, 2005 : 82-88.
  • 7Chung TW. CNS involvement in hemophagocytic lymphohistiocytosis: CT and MR findings [ J]. Korean J Radiol, 2007 ;8( 1 ) :78-81.
  • 8Allen CE, Yu X, Kozinetz CA, et al. Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer, 2008 ;50 : 1227-1235.
  • 9Risdall RJ, MckennaRW, Nesbit ME, et al. Virus-associated hemophagocytic syndrome: a benign histiocytic proliferationdistinct frommalignant histiocytosis[ J]. Cancer, 1979 ;44(3) :993-1002.
  • 10Janka GE. Familial and acquired hemophagocytic lymphohistiocytosis. Eur J Pediatr, 2007 ; 166:95-109.

共引文献75

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部